You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tofacitinib

Showing 26 - 50 of 258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs

Completed
  • Arthritis, Rheumatoid
    • Tokyo, Japan
      Pfizer
    Nov 28, 2022

    Adherence Of Tofacitinib of Ulcerative Colitis In Clinical

    Recruiting
    • Ulcerative Colitis
    • tofacitinib
    • Alingsås, Sweden
    • +12 more
    Nov 17, 2022

    Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)

    Recruiting
    • Systemic Lupus Erythematosus
    • Cutaneous Lupus
    • Tofacitinib
    • Ann Arbor, Michigan
      University of Michigan Health System: Department of Internal Med
    May 2, 2022

    Sarcoidosis, Pulmonary, Sarcoidosis Lung, Sarcoidosis Trial in Portland (drug, diagnostic test, genetic)

    Completed
    Has Results
    • Sarcoidosis, Pulmonary
    • +2 more
    • Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial
    • +5 more
    • Portland, Oregon
      Oregon Health & Science University
    Dec 3, 2021

    Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)

    Recruiting
    • Immune-Mediated Colitis
    • Tofacitinib 10 mg
    • Montreal, Quebec, Canada
      Sir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
    May 11, 2022

    Alopecia Areata Trial in Bangkok (Tofacitinib)

    Completed
    Has Results
    • Alopecia Areata
    • Tofacitinib
    • Bangkok, Thailand
      Institute of Dermatology
    Mar 28, 2022

    Rheumatoid Arthritis, Interstitial Lung Disease Trial in Mexico City (Tofacitinib)

    Recruiting
    • Rheumatoid Arthritis
    • Interstitial Lung Disease
    • Tofacitinib
    • Mexico City, Tlalpan, Mexico
      Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío V
    Apr 4, 2022

    Vitiligo, Effect of Drug Trial (JAK-2 inhibitor, Topical corticosteroid)

    Not yet recruiting
    • Vitiligo
    • Effect of Drug
    • JAK-2 inhibitor
    • Topical corticosteroid
    • (no location specified)
    Mar 19, 2022

    COVID-19 Pneumonia Trial in New Haven (Tofacitinib 10 mg, Placebo)

    Terminated
    • COVID-19 Pneumonia
    • Tofacitinib 10 mg
    • Placebo
    • New Haven, Connecticut
      Yale New Haven Health System
    Mar 16, 2022

    Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)

    Recruiting
    • Ulcerative Colitis
    • Thromboembolism
    • Tofacitinib
    • Infliximab Adalimumab y Golimumab
    • Madrid, Spain
      Hospital Universitario de La Princesa
    Aug 2, 2022

    Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)

    Recruiting
    • Primary Sjögren's Syndrome
    • Tofacitinib
    • Beijing, Beijing, China
      Department of Rheumatology and Immunology, Peking University Peo
    Feb 28, 2022

    TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular

    Completed
    • Rheumatoid Arthritis
    • Tofacitinib
    • TNF Inhibitor
    • Boston, Massachusetts
      Brigham And Women's Hospital
    Mar 1, 2022

    Patterns And Effect Of Tofacitinib Indicators For Rheumatoid

    Completed
    • Arthritis, Rheumatoid
      • New York, New York
        Pfizer
      Jun 8, 2022

      That Distinguish Between Tofacitinib Responders and

      Completed
      • Ulcerative Colitis
      • GWAS analysis by Illumina BeadChip
      • New York, New York
        New York University School of Medicine
      Aug 9, 2022

      Healthy Subjects Trial in Québec (Tofacitinib Citrate)

      Completed
      • Healthy Subjects
      • Tofacitinib Citrate
      • Québec, Canada
        Syneos Health Facility
      Nov 25, 2021

      Tofacitinib on Body Composition, Bone Mineral Density and Bone

      Suspended
      • Rheumatoid Arthritis
      • Tofacitinib
      • Lille, France
        Lille University Hospital
      Feb 7, 2022

      Tofacitinib PsA Initiators in the CorEvitas SpA Registry

      Active, not recruiting
      • Psoriatic Arthritis
        • New York, New York
          Pfizer
        Feb 8, 2022

        Discoid Lupus Erythematosus, Systemic Lupus Erythematosus Trial in Boston (Tofacitinib citrate)

        Terminated
        • Discoid Lupus Erythematosus
        • Systemic Lupus Erythematosus
        • Tofacitinib citrate
        • Boston, Massachusetts
          Tufts Medical Center
        Jan 6, 2022

        Ulcerative Colitis Trial in Chapel Hill

        Enrolling by invitation
        • Ulcerative Colitis
          • Chapel Hill, North Carolina
            Division of Gastroenterology and Hepatology
          Feb 21, 2022

          Down Syndrome, Regression Trial (Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib)

          Not yet recruiting
          • Down Syndrome
          • Regression
          • (no location specified)
          Dec 14, 2022

          Generate Real World Data On Tofacitinib Induction Therapy and

          Recruiting
          • Ulcerative Colitis
          • Stool sample collection
          • Bern, Bern (de), Switzerland
          • +8 more
          Jan 25, 2023

          Tofatib Treatment for IgG4-related Disease

          Recruiting
          • IgG4-related Disease
          • tofacitinib
          • Shanghai, Shanghai, China
            Shanghai Changhai Hospital
          Nov 15, 2022

          Takayasu Arteritis Trial in Beijing (Adalimumab Injection, Tofacitinib 5 MG)

          Recruiting
          • Takayasu Arteritis
          • Adalimumab Injection
          • Tofacitinib 5 MG
          • Beijing, China
          • +3 more
          Feb 26, 2022

          Ulcerative Colitis Trial in Miami (Tofacitinib, Fast Mimicking Diet, Ustekinumab induction)

          Recruiting
          • Ulcerative Colitis
          • Tofacitinib
          • +3 more
          • Miami, Florida
          • +1 more
          Apr 22, 2022

          Rheumatoid Arthritis, Therapy Trial in Jinan (Iguratimod)

          Recruiting
          • Rheumatoid Arthritis
          • Therapy
          • Jinan, Shandong, China
            Yanfeng Hou
          Nov 24, 2023